Your browser doesn't support javascript.
loading
HIV-1-Neutralizing IgA Detected in Genital Secretions of Highly HIV-1-Exposed Seronegative Women on Oral Preexposure Prophylaxis.
Lund, Jennifer M; Broliden, Kristina; Pyra, Maria N; Thomas, Katherine K; Donnell, Deborah; Irungu, Elizabeth; Muwonge, Timothy R; Mugo, Nelly; Manohar, Madhuri; Jansson, Marianne; Mackelprang, Romel; Marzinke, Mark A; Baeten, Jared M; Lingappa, Jairam R.
Afiliação
  • Lund JM; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA Department of Global Health, University of Washington, Seattle, Washington, USA jlund@fredhutch.org.
  • Broliden K; Department of Medicine, Karolinska Institute, Stockholm, Sweden.
  • Pyra MN; Department of Global Health, University of Washington, Seattle, Washington, USA.
  • Thomas KK; Department of Global Health, University of Washington, Seattle, Washington, USA.
  • Donnell D; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA Department of Global Health, University of Washington, Seattle, Washington, USA.
  • Irungu E; Partners in Health Research and Development, Kenya Medical Research Institute, Thika, Kenya.
  • Muwonge TR; Infectious Disease Institute, Makerere University, Kampala, Uganda.
  • Mugo N; Partners in Health Research and Development, Kenya Medical Research Institute, Thika, Kenya.
  • Manohar M; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Jansson M; Department of Laboratory Medicine, Lund University, Lund, Sweden.
  • Mackelprang R; Department of Global Health, University of Washington, Seattle, Washington, USA.
  • Marzinke MA; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Baeten JM; Department of Global Health, University of Washington, Seattle, Washington, USA Department of Medicine, University of Washington, Seattle, Washington, USA Department of Epidemiology, University of Washington, Seattle, Washington, USA.
  • Lingappa JR; Department of Global Health, University of Washington, Seattle, Washington, USA Department of Medicine, University of Washington, Seattle, Washington, USA Department of Pediatrics, University of Washington, Seattle, Washington, USA.
J Virol ; 90(21): 9855-9861, 2016 Nov 01.
Article em En | MEDLINE | ID: mdl-27558421
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoglobulina A / Infecções por HIV / HIV-1 / Anticorpos Neutralizantes Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans Idioma: En Revista: J Virol Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoglobulina A / Infecções por HIV / HIV-1 / Anticorpos Neutralizantes Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans Idioma: En Revista: J Virol Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Estados Unidos